Table 5.
Scale | No facial paresis | Facial paresis | BF | t | P | d |
---|---|---|---|---|---|---|
M (SD) | M (SD) | |||||
SWLS | 27.39 (6.37) | 23.17 (7.61) | 49.76 | 2.06 | .045 | 0.60 |
BFNE | 23.09 (7.82) | 27.00 (7.59) | 23.52 | 1.74 | .088 | 0.51 |
SADS | 11.41 (2.57) | 11.94 (3.75) | 2.46 | 0.56 | .580 | 0.16 |
BDI‐II | 6.65 (5.75) | 10.04 (7.85) | 20.64 | 1.68 | .099 | 0.49 |
Note: P represents significance based on directional (one‐tailed) t‐test. BF for the hypothesis that VS patients with facial paresis experience lower health‐related quality of life than VS patients without facial paresis.
Abbreviations: BDI‐II, Beck depression inventory; BF, Bayesian factor; BFNE, brief version of the fear of Negative Evaluation Scale; SADS, Social Avoidance and Distress Scale; SWLS, Satisfaction With Life Scale.